AB-101-001 single/multiple-ascending dose

A Phase 1a/1b clinical trial evaluating the safety, tolerability, and PK/PD of oral administration of AB-101 in healthy subjects and patients with cHBV infection.

The first subject has been dosed in the single ascending dose portion of this trial. 

Clinicaltrials.gov